(Fig. 7), suggesting that the lncRNA RASAL2-AS1/ METTL14/LIS1 axis might be a potential therapeutic target for head and neck squamous cell carcinoma patients. This evidence concerns the gene RASAL2 and head and neck squamous cell carcinoma.